Results 161 to 170 of about 106,545 (283)

Multi‐Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations

open access: yesPharmacology Research &Perspectives, Volume 13, Issue 4, August 2025.
ABSTRACT Alzheimer's disease (AD) is a complex and multifactorial neurodegenerative disorder, recognized as the most prevalent form of dementia. It is characterized by multiple pathological processes, including amyloid‐beta accumulation, neurofibrillary tangles, and neuroinflammation. The therapeutic efficacy of traditional single‐target drugs has been
Md Saad Hossain, Md Hamed Hussain
wiley   +1 more source

Imatinib mesylate (STI571) therapy for Philadelphia chromosome–positive chronic myelogenous leukemia in blast phase

open access: bronze, 2002
Hagop M. Kantarjian   +11 more
openalex   +1 more source

Imatinib administration in two patients with liver metastases from GIST and severe jaundice [PDF]

open access: hybrid, 2003
Tommaso De Pas   +4 more
openalex   +1 more source

Chronic myeloid leukemia outcomes according to baseline risk and first‐line treatment in real‐world settings: Data from the Italian Network/CML Campus

open access: yesCancer, Volume 131, Issue 13, 1 July 2025.
Abstract Background Improved outcome has been reported in chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) in sponsored trials. Methods This is a multicenter prospective cohort study of consecutive patients with newly diagnosed chronic phase CML from 19 regions in Italy.
Valentina Giai   +44 more
wiley   +1 more source

Is there a cloud in the silver lining for imatinib? [PDF]

open access: hybrid, 2003
Sarah Paterson   +3 more
openalex   +1 more source

Clinical Presentation and Diagnosis of Multisystemic Eosinophilic Epitheliotropic Disease in a Miniature Donkey: A Case Report

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT A 21‐year‐old miniature donkey gelding was evaluated for pruritus, inappetence, hypertriglyceridemia, and alopecia of 2 weeks' duration. Hematology showed moderate eosinophilia, severe hypertriglyceridemia, and moderately increased liver enzyme activities. Cytologic evaluation of peritoneal fluid identified an eosinophilic transudate.
Carla K. Enriquez   +4 more
wiley   +1 more source

CNS and Cutaneous Involvement in Patients With Chronic Myeloid Leukemia Treated With Imatinib in Hematologic Complete Remission: Two Case Reports [PDF]

open access: bronze, 2003
Elisabetta Abruzzese   +10 more
openalex   +1 more source

Imatinib in breast milk [PDF]

open access: yesAnnals of Hematology, 2009
Kronenberger, Roland   +5 more
openaire   +3 more sources

Recent Green and Sustainable Pd‐Catalyzed Aminations

open access: yesChemSusChem, Volume 18, Issue 12, June 17, 2025.
Herein, several sustainable methods toward Pd‐catalyzed aminations of aryl/heteroaryl (pseudo)halides with alkyl and (hetero)aryl amines are discussed. The use of bio‐derived solvents or recyclable aqueous micellar media allows for reduced Pd loadings without using egregious organic solvents.
John Michael Saunders   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy